µ²ºc¦¡ |
|
Epoetin beta»P³h¦å±wªÌ§¿²G¤¤¤ÀÂ÷¥Xªº¬õ¦å²y¥Í¦¨¯À¦³¬Û¦Pªº®ò°ò»Ä©MºÒ¤ô¤Æ¦Xª«²Õ¦¨¡C
|
UpToDate |
UpToDate ³sµ²
|
ÃIJz§@¥Î |
|
¬õ¦å²y¥Í¦¨¯À¬O¤@ºØÁÞ³J¥Õ¡A¬°¨ë¿E¬õ¦å²y¥Í¦¨«eÅXª«¥Í¦¨¬õ¦å²yªº¥Íªø¦]¤l¡C¥¦¥i§@¬°¦³µ·¤Àµõ¨ë¿E¦]¤l¥H¤Î¤À¤Æ¶Pº¸»X¡C
|
¾AÀ³¯g |
|
1. ªvÀøºC©ÊµÇ°IºÜ¥B¦ñÀH¯gª¬©Ê³h¦å¯f¤H¡C 2. ªvÀø»PÀù¯g¤Æ¾ÇªvÀø¦³Ãöªº¯gª¬©Ê³h¦å¡C 3. ªvÀø¥¿¦b±µ¨ü§Ü¸~½FªvÀø¤§¦hµo©Ê°©Åè½F¡B§C«×«D¦óªNª÷¤ó²O¤Ú½F©ÎºC©Ê²O¤Ú©Ê¥Õ¦å¦¨¤H±wªÌªº¯gª¬©Ê³h¦å¡C
|
¥Îªk¥Î¶q |
|
°w¹ï±w¦³ºC©ÊµÇ°IºÜªº³h¦å¯f¤H¤§ªvÀø¡G ¹ïºC©ÊµÇ°IºÜ¯f±w¡A¨äªvÀøªº¥Ø¼Ð¦b¦å¬õ¯ÀȹF¨ì10-12 g/dl¡A¤£¥i¶W¥X12 g/dl ¡C¦pªG¦å¬õ¯À¦b4 ¶g¤º¤É°ª¦Ü¶W¹L2 g/dl (1.3 mmol/l)ªºµ{«×¡A«hÀ³¦Ò¼{±N¾¯¶q°§C¡C ªvÀø¥i¤À¬°¨âÓ¶¥¬q¡G 1. ½Õ¾ã¶¥¬q¡G ¥Ö¤Uª`®g(¾A¥Î©ó©Ò¦³¾¯«¬)¡Gªì¾¯¶q¬O¨C¶g3¡Ñ20 IU/kg Åé«¡CY¦å¬õ¯ÀȼW¥[¤£²z·Q(¨C¬P´Á§C©ó0.25 g/dl)¡A¸Ó¾¯¶q¥i¥H¨C¥|¶g¬°¶¡¹j¡A¨C¶g¼W¥[3¡Ñ20 IU/kg Åé«¡C¨C¶g¤§¾¯¶q¤]¥i¤À¦¨¨C¤é§ë»P¡C ÀR¯ßª`®g(¾A¥Î©óá´¹¤Îª`®g·»²G¥Î·»¾¯¤Î°wµ©¸Ëª`®g·»²G)¡Gªì¾¯¶q¬O¨C¶g3¡Ñ40 IU/kg Åé«¡C¨ä¾¯¶q¥i¦b¥|¶g«á¼W¥[¨ì80 IU/kg Åé«¡A¨C¶gµ¹¤T¦¸¡CY»Ý¶i¤@¨B¼W¥[¾¯¶q¡A¥i¥H¥H¤ë¬°¶¡¹j¡A¼W¥[´T«×¬°¨C¶g3¡Ñ20 IU/kgÅé«¡C «ez¨âºØµ¹Ãij~®|¡A³Ì¤j¾¯¶q¤£À³¶W¹L¨C¶g720 IU/kg Åé«¡C 2. ºû«ù¾¯¶q¶¥¬q¡G¬°¤Fºû«ù¥Ø¼Ð¦å¬õ¯ÀȤj¬ù¦b10-12 g/dl ¤§¶¡¡A¾¯¶q¥ý°¬°¥ý«e¨Ï¥Î¶qªº¤@¥b¡CÀH«á¡A¥H¤@¨ì¤G¶g¬°¶¡¹j¡AÓ§O¬°¯f¤H½Õ¾ã¾¯¶q(ºû«ù¾¯¶q)¡C„« ªvÀø©TºA¸~½F±wªÌªº¯gª¬©Ê³h¦å¡G 1. ¥»»s¾¯¸g¥Ñ¥Ö¤Uª`®g¡F¥i¤@¦¸ª`®g¤@¶gªº¾¯¶q©Î±N¤@¶gªº¾¯¶q¤À¦¨¤T¦Ü¤C¦¸ª`®g¡C«Øijªì©l¾¯¶q¬°¨C¶g450 IU/kg Åé«¡C 2. ³Ì°ª¾¯¶q¤£¥i¶W¹L¨C¶g¨C¤½¤çÅé«900 IU¡C„« ªvÀø¦hµo©Ê°©Åè½F¡B§C«×«D¦óªNª÷¤ó²O¤Ú½F©ÎºC©Ê²O¤Ú©Ê¥Õ¦å¯f±wªÌªº¯gª¬©Ê³h¦å¡G 1. «Øij°_©l¾¯¶q¬°¨C¶g¨C¤½¤çÅé«450 IU¡C 2. ³Ì°ª¾¯¶q¤£¥i¶W¹L¨C¶g¨C¤½¤çÅé«900 IU¡C
|
ÃİʤO¾Ç |
|
§l¦¬ ¸g¥Ö¤Uª`®gepoetin beta ¨ì§¿¬r¯g¯f±w«áµo²{¡A©µªø©Êªº§l¦¬§@¥Î·|¾ÉP¦å²M¿@«×°ªì¡A¥§¡¦b12-28 ¤p®É«á¹F¨ì³Ì¤j¿@«×¡C¸g¥Ö¤Uª`®gepoetin beta ¤§¥ÍÅé¥i¥Î²v¬°ÀR¯ßª`®gªº23-42%¡C ¤À§G °w¹ï°·±d§ÓÄ@ªÌ»P§¿¬r¯g±wªÌ©Ò¶i¦æªºÃĪ«°Ê¤O¾Ç¬ã¨sÅã¥Ü¡A¨ä¤À§GÅé¿n¬Û·í©ó¦å¼ß®e¿nªº¤@¦Ü¨â¿¡C ±Æ°£ °w¹ï°·±d§ÓÄ@ªÌ»P§¿¬r¯g±wªÌ©Ò¶i¦æªºÃĪ«°Ê¤O¾Ç¬ã¨sÅã¥Ü¡A¸gÀR¯ßª`®g§ë¤©¤§epoetin beta ªº¥b°I´Á¬°4 ¦Ü12 ¤p®É¤§¶¡¡C ¹ï§¿¬r¯g±wªÌ¥Ö¤Uª`®gepoetin beta ¤§³Ì²×¥b°I´Án¤ñÀR¯ßª`®g®Éªø¡A¥§¡¬°13-28¤p®É¡C
|
°Æ§@¥Î |
|
°ª¦åÀ£¡BÀYµh¡C
|
¥æ¤¬§@¥Î |
|
¥Ø«e¨Ã¥¼¶i¦æ¥ô¦ó°w¹ï¥æ¤¬§@¥Î¤§Á{§É¬ã¨s¡C ¨Ì¥Ø«eªºÁ{§É¸gÅç¬Ý¨Ó¡A¨Ã¥¼µo²{¥ô¦óÃÒ¾ÚÅã¥Ü¥i¯à¦³»P®e¥i°Ò²£¥Í¥æ¤¬§@¥ÎªºÃĪ«¡C
|
¸T§Ò |
|
1. ¤wª¾¹ï¥»«~¤§¬¡©Ê¦¨¤À©Î¥ô¤@½á§Î¾¯¹L±Óªº±wªÌ¡C 2. °ª¦åÀ£±±¨î¤£¨}ªº±wªÌ¡C
|
µ¹¥I³W©w |
|
4.1.1.¬õ¦å²y¥Í¦¨¯À(²ºÙEPO )hu-erythropoietin (¦pEprex¡BRecormon)¡Bdarbepoetin alfa¡]¦pAranesp ¡^¡Bmethoxy polyethylene glycol-epoetin beta¡]¦p Mircera solution for injection in pre-filled syringe)¡^¡G(93/5/1¡B95/11/1¡B96/10/1¡B98/1/1¡B98/9/1¡B104/12/1¡^ ¨Ï¥Î«eÀ³§@Å餺ÅK½è¶J¦sµû¦ô¡A¥H«á¤T¦Ü¤»Ó¤ë°lÂÜ¡C 1.¨Ï¥Î«e©MªvÀø«á¨C¤T¦Ü¤»Ó¤ëÀ³§@Å餺ÅK½è¶J¦sµû¦ô¡A¦pHb¦b8gm/dL¥H¤U¡A¥Bferritin¤p©ó100mg/dL(«D³zªR¯f¤H)¡B©Î200 mg/dL(³zªR¯f¤H)¡A¦³¥i¯à¬OÅK½è¯Ê¥F¡C(104/12/1)¡C 2.¨Ï¥Î´Á¶¡À³±Æ°£ºû¥L©RB12©Î¸»Ä¯Ê¥F¡A¸zG¹D¥X¦å¡A¥þ¨©Ê·P¬V©Îµoª¢¯e¯fµ¥±¡ªp¡A©l±oÄ~Äò¡C(104/12/1)¡C 3.µÇŦ¯f¨Ã²Å¦X¤U¦C±ø¥ó¨Ï¥Î¡G(104/12/1) (1)¥½´ÁµÇŦ¯f±µ¨ü³zªR¯f¤H¡A¨äHb<9gm/dL¡A©Î²Ä¤´ÁºC©ÊµÇŦ¯f¯f¤H (eGFR < 15 mL/min/1.73m2)¡A¨äHb < 9gm/dL¡C ¢¹.¨Ï¥Î®É¡AÀ³±q¤p¾¯¶q¶}©l¡AHb¥Ø¼Ð¬°10 gm/dL¡A²Å¦X¤U¦C±¡§Î¤§¯f¤H¡AÀ³§Y¼È°±¨Ï¥Î¥»ÃþÃÄ«~¡G i. Hb¶W¹L11gm/dL¡C ii.±µ¨üªvÀø²Ä6¶g¨ì²Ä8¶g¤ºHb¤§¤W¤ÉÈ¥¼¹F1 gm/dL¡C ¢º.¦pHbȺû«ù¦b¥Ø¼ÐȤ@¬q®É¶¡ (¤@¦Ü¤GÓ¤ë)¡A©y³v¦¸´î¶q¡A¥H¨D±o³Ì§Cºû«ù¾¯¶q¡C (2)¨C¦W¯f¤H©Ò¥Î¾¯¶q¡A¤@Ӥ뤣¶W¹L20,000U (¦pEprex¡BRecormon)©Î100mcg (¦pAranesp ¡BMircera solution for injection in pre-filled syringe)¬°ì«h¡A¦p»Ý¶W¶q¨Ï¥Î¡AÀ³ªþ¯f¤HÁ{§É¸ê®Æ(¦p¦~ÄÖ¡B«e¤ëHbÈ¡B«e¤ë©Ò¥Î¾¯¶q¡B©Ò©w¥Ø¼ÐÈ¡Kµ¥µ¥)¤Î¨Ï¥Î²z¥Ñ¡C(93/5/1¡B98/9/1)¡C (3)¨Ï¥Î¥»ÃþÃÄ«~¤§¬~µÇ±wªÌ¡A¨C¶gÀ³ÀˬdHbȤA¦¸¡ACAPD¤Î¥¼³zªR±wªÌ¡A¦p¦]¯f±¡»Ýn¨Ï¥Î¥»ÃþÃÄ«~®É¡A¨C¤ëÀ³ÀˬdHbȤA¦¸¡CÀˬd¶O¥Î¥]§t©ó³zªR¶O¥Î¤º¡A¤£¥tµ¹¥I(¥¼±µ¨ü³zªR¯f¤H°£¥~)¡C (4)¨Ï¥Î¥»ÃþÃÄ«~´Á¶¡¦p»Ý¿é¦å¡A½Ðªþ¿é¦å®ÉHbȤÎì¦]¡C 4.Àù¯g¯f¤H¦X¨Ö¤Æ¾ÇªvÀø¦³Ãöªº³h¦å¡C¤£§t¨Ï¥ÎMircera solution for injection in pre-filled syringe¡G¡]95/11/1¡B96/10/1¡B98/1/1¡B98/9/1¡B104/12/1¡^ (1)±w¦³©TºA¸~½F±µ¨ü¤Æ¾ÇÃĪ«ªvÀø¦Ó¤Þ°_¤§¯gª¬©Ê³h¦å¡A¥BHb¡Õ8 gm/dL¤§¯f¤H¨Ï¥Î¡C¹ï©óÀù¯g±wªÌ¹w´Á¦³¦X²z¥B¨¬°÷ªº¦s¬¡®É¶¡ªÌ¡]§tªv¡©ÊªvÀø¤Î¹w´Á»²§U©Ê¤Æ¾ÇªvÀøµ¥¡^¡A¤£À³¨Ï¥ÎEPOªvÀø³h¦å¡C¡]98/1/1¡B104/12/1¡^ (2)Epoetin beta¡]¦pRecormon¡^»Pepoetin alfa¡]¦pEprex¡^ªì¾¯¶q¬°150U/Kg ¨C¶g3¦¸¡A³Ì°ª¾¯¶q300U/Kg¨C¶g3¦¸¡A©Îepoetin beta¡]¦pRecormon¡^ªì¾¯¶q30,000³æ¦ì¡Aepoetin alfa¡]¦pEprex¡^ªì¾¯¶q40,000³æ¦ì¡A¨C¶g1¦¸¡A³Ì°ª¾¯¶q60,000³æ¦ì¡A¨C¶g1¦¸¡FDarbepoetin alfa¡]¦pAranesp¡^ªì¾¯¶q2.25mcg/kg¡A¨C¶g1¦¸¡A³Ì°ª¾¯¶q4.5mcg/kg¡A¨C¶g1¦¸¡C¡]96/10/1¡^¡C (3)¨C¦¸Àøµ{³Ìªø24¶g¡A¦p¤Æ¾ÇªvÀøÀøµ{§¹¥þµ²§ô«á4¶g¤]À³°±¤îEPO¨Ï¥Î¡C(104/12/1¡^ (4)²Å¦X¤U¦C±¡§Î¤§¯f¤H¡AÀ³§Y°±¤î¨Ï¥Î¥»ÃþÃÄ«~¡G ¢¹.Hb¶W¹L10 gm/dL (Hb¡Ö10gm/dL)¡C ¢º.©ó±µ¨üªvÀø²Ä6¶g¨ì²Ä8¶g¤ºHb¤§¤W¤ÉÈ¥¼¹F1 gm/dL¡C ¢».¤Æ¾ÇªvÀøµ²§ô«á4¶g(104/12/1¡^¡C
|
ª`·N¨Æ¶µ |
|
¬°½T«O¹F¨ì¦³®Äªº¬õ¦å²y¥Í¦¨§@¥Î¡A©Ò¦³ªº±wªÌ¦bªvÀø«e»PªvÀø´Á¶¡³£À³µû¦ôÅK½èª¬ºA¡A¨Ã¥i¯à¥²¶·¨Ì¾ÚªvÀø«ü¥Ü¶i¦æÅK¾¯¸É¥RªvÀø¡C
|
ĵ»y |
|
¬õ¦å²y¥Í¦¨¨ë¿E¯À¦³¼W¥[¸~½F´c¤Æ©Î´_µoªº·ÀI¡C
|
¹L¶q³B²z |
|
®e¥i°ÒªºªvÀø½d³ò·¥¼s¡A¦ý¶}©l¨Ï¥Î®e¥i°ÒªvÀø®É¡A¤´¶·ª`·NÓ§O¯f±wªºªvÀø¤ÏÀ³¡C¨Ï¥Î¹L¶q¥i¯à·|¤ÞµoÃĮħ@¥ÎÂX¤jªºªí²{¡A¦p¬õ¦å²y¥Í¦¨¹L¶q¡A³o¥i¯à·|¦ñÀHµo¥Í¨ã¥Í©R«Â¯Ù©Êªº¤ß¦åºÞ¨t²Î¨Öµo¯g¡C¦pªG¦å¬õ¯ÀȹL°ª¡A«hÀ³¼È®É°±¥Î®e¥i°Ò¡C¦pªGÁ{§Éª¬ªpÅã¥Ü¦³¥²n¡A©Î¥i¶i¦æÀR¯ß¬ï¨ë©ñ¦å¡C
|
ÃÄ«~«O¦s¤è¦¡ |
|
ºû«ù·Å«×¦b2 ¨ì 8¢XC¡C(¦s©ñ¦b¦B½c)¡A±N¤p²~/°wµ©¸Ë®e¾¹«O¦s¦b¥~²°¤¤¥HÁ×¥ú¡C
|